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Abstract: Two-hundred-and-twenty-seven children underwent orthotopic 
liver transplantation between March 1980 and March 1986. Seventy (31 %) 
patients died during the study period. Four patients who died within 24 
hours of the initial liver transplant and 5 patients who died outside of our 
institution were excluded from the analysis. Liver failure, related to either 
thrombosis of the hepatic artery, primary non-function of the graft or 
rejection accounted for 25 of the remaining 61 deaths. In 21 patients 
death was related to overwhelming sepsis while 7 patients died from excess-
ive bleeding. Eight of the deaths were due to a miscellaneous group of 
causes. Twenty percent of the 150 patients who received a single liver 
transplant died compared to a death rate of 50% in patients who under-
went three transplants. Eighty-five percent of the deaths occurred within 
6 months after the initial liver transplant. Liver failure was the cause in 
the majority of the early deaths whereas the later deaths were more likely 
to be due to sepsis. This detailed analysis of the causes of death after 
pediatric liver transplantation in a large group of patients has revealed 
that advances in certain areas could lead to even better results. 
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The first human orthotopic liver transplant was 
performed in Denver in March 1963 (1). However, 
the early results from Denver and Cambridge (2), 
the first two major centers performing liver trans-
plants. were less than satisfactory with only about 
25% of the patients surviving more than I yr (3). 
The deaths in the early post-operative period were 
related to technical complications and bleeding, 
overwhelming sepsis associated with high steroid 
administration and biliary complications (3, 4). 
There has been marked improvement in results in 
the last 7 yr. with 5-yr survival in the largest series 
approaching 70%. The reasons for these extremely 
encouraging results have included refinements in 
the operative technique (5), including the use of 
the veno venous bypass during the anhepatic phase 
(6). improvements in biliary reconstruction (7), im-
proved methods of organ harvesting and preser-
vation (8), and aggressive retransplantation (9). 
However. the major advance in liver transplan-
tation has been the introduction of the immuno-
suppressive agent cyclosporine in 1978 (10). The 
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use of cyclosporine in combination with steroids 
was introduced in March 1980 (II). The I-yr sur-
vival rates for adults and children undergoing liver 
transplantation with this regimen have exceeded 
70% (12). We have recently reported the compli-
cations and causes of death in adult liver transplan-
tation in the cyclosporine era (13). The present 
report represents a retrospective analysis of the 
causes of death in pediatric liver transplantation 
using cyc1osporine-steroid immunosuppression. 
Patlenb an~ lfello~K 
Two-hundred-and-twenty-seven pediatric patients 
who underwent orthotopic liver transplantation at 
the Children's Hospital of Pittsburgh between 
March 1980 and February 1986 were retrospec-
tively evaluated. Sixty-three patients received two 
liver transplants. and 14 patients received three 
transplants. Only patients who survived the im-
mediate post-operative period (24 h) after the first 
liver transplant were included in the study. 
Our methods for patient selection, techniques 
for orthotopic liver transplantation, protocols for 
immunosuppressive management and post-operat-
ive care have been described in detail previously 
(3. 5. 14). All liver transplant recipients received 
p 
comparable clinical management and, in particular, 
all patients received combination cycJosporine and 
steroids after the transplant (11). 
The age range of the 227 patients was 3 wk to 
18 yr (mean 6.11 yr). The indications for liver 
transplantation in the 227 children are listed in 
Table I. Nearly half of the patients had biliary 
atresia. Alpha-I-antitrypsin deficiency was the sec-
ond most common indication for transplantation. 
Biliary atresia/hypoplasia and the hepatic-based in-
born errors of metabolism accounted for 75% of 
the patients. 
During the study period, 70 of the 227 patients 
died (31 %). Four patients who died either during 
or within 24 h of the initial liver transplant were 
excluded. The causes of death in these 4 patients 
were: cardiac failure, uncontrolled bleeding, liver 
failure and septicemia. A further 5 patients who 
died outside of Pittsburgh were also excluded be-
cause there were insufficient details available to 
accurately determine the cause of death. The re-
maining 61 patients formed the basis for the analy-
sis of the causes of death after pediatric liver trans-
plantation. Complete autopsies were performed in 
43 of the 61 patients and the cause of death in 
these patients was based upon clinical details as 
well as the autopsy findings. In the remaining 18 
patients in whom an autopsy was not performed, 
the cause of death was determined using clinical 
criteria. 
Causes of death 
Although there were usually many factors which 
contributed to the death of the liver transplant 
pediatric patient, only one cause of death was as-
cribed to each patient. Thrombosis of the hepatic 
artery was determlllt:J by either ultrasound or angi-
ography, or both. and confirmed at autopsy in the 
autopsied patients. The histological criteria used 
for rejection have been documented previously (15, 
16). In brief, early rejection consisted of a portal 
and/or a lobular mixed inflammatory infiltrate, dis-
ruption of the limiting plate, a characteristic bile 
duct injury and occasional portal vein endothelitis. 
Chronic rejection consisted of either a vascular 
injury of the medium-sized hilar arteries with sub-
endothelial foam cells, fibrinoid necrosis and inti-
mal hyperplasia. or periportal bridging fibrosis as-
sociated with disappearance of the interlobular bile 
ducts. Primary non-function of the graft refers to 
those transplants which did not function at all 
despite patency of all vessels and no evidence of 
rejection. These patients had progressive elevation 
of the bilirubin and transaminases, severe coagul-
opathy, hypoglycemia, renal failure and encepha-
lopathy. Infection was recognized as the cause of 
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death if it was the major diagnosis established at 
autopsy, or if completely documented infection was 
the major factor in the patient's clinical deterio-
ration just prior to death. The etiology of the infec-
tion was determined either by appropriate cultures 
and stains or histologically. 
Results 
A cause of death could be accurately determined 
in 61 of the 70 patients who died during the study 
period. There were 26 males and 35 females and 
the age range was 7 months to 18 yr (mean 6.07 ± 
0.6 yr). The indications for liver transplantation in 
the 61 patients who died are listed in Table 1. The 
majority of the patients who died were transplanted 
for biliary atresia/hypoplasia, but this diagnosis 
represents the most common indication for trans-
plantation in the entire pediatric group (12). Twen-
ty-seven and 23% of the patients with biliary 
atresia/hypoplasia and metabolic disorders, respec-
tively, died during the study period. The death rates 
in patients with cirrhosis and neonatal hepatitis 
were low. All the patients who were transplanted 
for acute hepatic failure died. 
Liver faifure 
The causes of death in the 61 patients who died 
after liver transplantation are shown in Table 2. 
Liver failure was the primary cause of death in 25 
patients. In II patients the liver failure was due 
Table 1. EtiolOOY of the liver diseases encountered In 227 patients undergoing 
liver transplantation and in the 70 deaths after liver transplantation 
(1) Biliary atresia/hypoplaSia 
Biliary atresia 
Alagilles syndrome 
(2) Metabolic Disorders 
Alpha-1·antitrypsln deficiency 
Wilsons disease 
Glycogen storage disease 
Tyrosinemia 
OIher 
(3) Cirrtlosis 
Chronic active hepatitiS 
Other 
(4) Familial cholestasis 
(5) Acute hepatiC failure 
Fulminant hepatitiS 
Drug-induced 
(6) Neonatal hepatitis 
(7) Miscellaneous 
t Oied WltIlin 24 hours after the transplant 
• Died outSide of Pittsburgh. 
Total Deaths 
107 32ttt-
13 7 
30 6 
6 2 
5 2 
5 2' 
2 2 
10 3 
16 
10 4 
3 3 
2 2 
7 10' 
11 6 
227 70 
151 
---
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Table 2. Causes of death after pediatric liver transplantation 
Liver failure: 
Hepatic artery thrombosIS 
Primary non·function 
Severe relection 
Inlection: 
Viral 
Bacterial 
Fungal 
Other 
Bleeding: 
Intra-operative 
Ruptured mycotic aneurysm 
Miscellaneous: 
Lymphoproliferative disease (2) 
Recurrent hepatoma (1) 
Small intestme infarction (1) 
cardiac failure after cardiac transplant (1) 
Hyerkalemia (1) 
Post-operatlVe brain death (2) 
11 
9 
5 
6 
8 
6 
4 
3 
8 
61 
to thrombosis of the hepatic artery. One of these 
patients developed a clostridial infection in the liver 
and died in the operating room during an explora-
tory laparotomy. A 2nd patient with a thrombosed 
hepatic artery developed a bile-stained hepatic ab-
scess and also had mild rejection. In 2 other pa-
tients, thrombosis of the artery was complicated by 
massive varicela hemorrhage in I and disseminated 
sepsis in the other. Occlusion of the hepatic artery 
was thought to be due to kinking of the artery and 
intense vasospasm in 2 patients. 
Nine patients died from liver failure resulting 
directly from primary non-function of the graft. 
Six of these patients underwent retransplantation 
for primary non-function of the initial transplant. 
Five of these 6 patients died between I and 3 d 
after the retransplant from irreversible brain dam-
age and I patient had a cardiac arrest during the 
retransplant. The remaining 3 patients died while 
awaiting retransplantation. 
Liver failure caused by severe rejection account-
ed for 5 deaths. All 5 patients experienced multiple 
complications. usually septic in nature. One patient 
had severe rejection accompanied by cytomegalovi-
rus pneumonia and candida peritonitis. Another 
patient had rejection and cytomegalovirus hepa-
titis. One patient with severe chronic rejection de-
veloped overwhelming E coli sepsis. The remaining 
2 patients with severe rejection also had generalized 
sepsis. 
Infection 
Overwhelming sepsis, wh~ch most often represents 
counted for 21 deaths in this study. In most patients 
the sepsis was due to multiple organisms (i.e., 
mixed bacterial, viral, fungal). However, in 8 pa-
tients the major component was of bacterial origin. 
In 4 of these 8 patients, the sepsis was related to a 
perforation of the small bowel, necrosis of the small 
bowel, a leak from the Roux-en-Y anastomosis, 
and a perforation of the colon, respectively. The 
last-mentioned patient also had cytomegalovirus 
hepatitis and candida peritonitis. Two patients had 
staphylococcal septicemia, which was complicated 
by staphylococcal endocarditis in I. Another pa-
tient, with a patent hepatic artery, developed a 
hepatic abscess and also had a cytomegalovirus 
pneumonia. 
Predominantly viral infections accounted for 6 
deaths. Four patients had disseminated cytomega-
lovirus infection with significant cytomegalovirus 
hepatitis. Two patients developed disseminated 
varicella infection 4 and 12 months after the liver 
transplant. 
Six 'patients died as a result of overwhelming 
fungal infection. Three of these patients had dis-
seminated candida sepsis and 2 patients had dis-
seminated aspergillus. One of the latter patients 
developed the aspergillus soon after retransplan-
tation for chronic rejection. The remaining patient 
had both disseminated aspergillus and candida sep-
sis, accompanied by cytomegalovirus hepatitis. 
One patient with chronic rejection developed 
pneumocystis infection 9 months after the trans-
plant and died. 
Bleeding 
Severe hemorrhage was the cause of death in 7 
patients. In 3 of these, hemorrhage was due to 
rupture of a mycotic aneurysm. In I of the latter 
patients the mycotic aneurysm was situated at the 
anastomotic site of an iliac graft to the aorta. Two 
patients with intraperitoneal sepsis died from un-
controllable bleeding during exploratory lapar-
otomy. Another patient exsanguinated during an 
exploratory laparotomy, as a result of an abscess 
eroding into the portal vein. The remaining patient 
died from bleeding during retransplantation for 
chronic rejection. 
Miscellaneous 
The miscellaneous causes of death included Iym-
phoproliferative disease (2 cases), recurrent hepa-
toma (1 case), infarction of the small intestine due 
to an internal hernia (1 case), cardiac failure in a 
patient who received a combined heart and liver 
transp~ant (1 ~aseFI and hyperkalemia in. the. post-
__ • ____ '0 ____ _ 
case). Another patient, with an anomalous inser-
tion of the superior vena cava into the infra-renal 
vena cava, was found to be brain-dead postopera-
tively, probably due to occlusion of the venous 
drainage of the upper extremity when the lower 
vena cava along with its anomalous superior vena 
caval insertion was clamped during the transplant 
procedure. One other patient. with evidence of 
brain-death preoperatively remained so after the 
liver transplant. 
TIme interval between transplant and death 
The time interval between the initial liver trans-
plant and the death of the patient, and its relation-
ship to the causes of death, are shown in Fig. I. 
Twenty-eight of the deaths occurred within the 1st 
month after the initial liver transplant and 85% of 
the deaths occurred within 6 months. Only 3 of the 
deaths occurred after the 1st yr following the first 
transplant. 
The majority of the early deaths were due to 
liver failure and the late deaths were more likely 
to be due to sepsis. Liver failure was the primary 
cause of death in 18 of the 28 patients who died 
within the 1st month after transplant. All of the 
deaths due to primary non-function of the graft 
occurred within the 1st month and all but 4 of the 
deaths due to liver failure occurred within the first 
3 months. Overwhelming sepsis tended to be the 
primary etiology of the later deaths. The time inter-
val between the transplant and death in patients 
who had disseminated viral infections was greater 
than I month. Similarly, 6 of the 7 deaths due to 
bleeding occurred after the I st month. 
Retransplantation and death 
Thirty of the 150 patients who received a single 
liver transplant died during the study period. This 
MONTHS 
MISC E LLANEOUS 
BLEEDING 
o INFECTION 
_ LIVER FAILURE 
Fig. J. The relationship of the causes of death to the time 
inte~al between the initial liver transplant and the eventual 
death of the patient. 
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compares with death rates of 38% and 50% in 
patients who received two and three transplants, 
respectively. 
Dlscusslaa 
This report represents the first detailed analysis of 
the causes of death in the largest consecutive group 
of pediatric liver transplants during the cyclospo-
rine era. Seventy of the 227 pediatric patients who 
underwent liver transplantation died during the 
study period. The primary causes of death in the 
61 patients available for analysis included: liver 
failure, overwhelming sepsis, excessive bleeding, 
and a miscellaneous category of various etiologies. 
Thrombosis of the hepatic artery accounted for 
11 of the deaths due to liver failure. It is a devastat-
ing complication leading to death or necessitating 
retransplantation, and the incidence after liver 
transplantation has been reported to range from 
3.7% to 10.7% (17). The presentation of hepatic 
artery thrombosis is varied and may mimic other 
complications; patients present with a fever, elev-
ated transaminases, fulminant hepatic necrosis, ne-
crosis of the bile duct with leakage of bile, and 
relapsing bacteremia singly or in any combination. 
In many patients, urgent retransplantation is re-
quired. However, a significant number of patients 
can survive for somewhat prolonged periods with 
a dearterialized graft. The mortality rate, even with 
retransplantation. is approximately 37.5% in 
children (18). The etiological factors which lead to 
hepatic artery thrombosis remain unresolved. 
Some of the factors which may playa role include 
technical problems, immunological phenomena 
and overzealous correction of the coagulopathy. 
Nine of the deaths due to liver failure were re-
lated to primary non-function of the graft. The 
underlying factors leading to primary graft non-
function include instability of the donor, inad-
equate preservation, prolonged cold ischemia, and 
prolonged warm ischemia. However. the relative 
contribution and importance of each of these fac-
tors remains undetermined and the ability to pre-
dict graft function after transplantation using stan-
dard criteria relating to these factors is still imposs-
ible (19). Patients present with progressive 
elevation of the bilirubin and transaminases. severe 
coagulopathy, hypoglycemia. renal failure. and en-
cephalopathy. The majority of these patients re-
quire urgent refransplantation. However. there still 
exists a significant mortality even with retransplan-
tation. 
Retransplantation is the treatment of choice in 
the majority of patients with hepatic artery throm-
bosis and primary graft non-function. However, 
the lack of suitable pediatric donors continues to 
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be a significant deterrent to further improvement 
in the survival results. The use of partially hepatec-
tomized grafts from adult donors may be a solution 
(20), and requires further evaluation. 
Severe rejection unresponsive to therapy and 
leading to liver failure and death is not commonly 
seen, and accounted for only 5 deaths in this series. 
However, many deaths are indirectly related to 
rejection; overwhelming sepsis, which represented 
a major cause of death in this study, is clearly a 
complication of over-immunosuppression in pa-
tients with proven or suspected rejection. 
Opportunistic infections are always a major con-
cern in immunosuppressed patients, particularly 
when the doses of the immunosuppressive agents 
have been increased to treat episodes of rejection. 
Bacterial infections are usually concentrated in the 
1st and, to a lesser extent, in the 2nd and 3rd 
months after transplantation. Intra-abdominal and 
intra-thoracic infections, in the form of intra-per-
itoneal abscesses, intra-hepatic abscesses and pneu-
monia, predominate. A significant number of 
deaths due to bacterial infections were related to 
spontaneous bowel perforations and anastomotic 
leaks. 
Fungal infections present a special problem after 
liver transplantation and are associated with a high 
degree of morbidity and mortality (21). Most infec-
tions are due to candida, but patients occasionally 
acquire aspergillus, cryptococcus and nocardia in-
fections. Risk factors associated with fungal infec-
tions include the use of high-dose steroids for pro-
ven or suspected rejection episodes. heavy periop-
erative blood loss, prolonged stay in the intensive 
care unit, intensive and prolonged antibiotic ther-
apy and surgery of the gastrointestinal tract. There 
was only I death due to Pneumocystis carnii and 
it occurred in a patient with chronic rejection 8 
months after the transplant. 
Disseminated viral infections due to cytomegalo-
virus and varicella accounted for 6 deaths in this 
series. Two other patients developed lymphoproli-
ferative disorders related to Epstein-Barr virus. A 
significant number of the other deaths were associ-
ated with localized viral infection in the form of 
hepatitis and pneumonia. Cytomegalovirus hepa-
titis in the presence of rejection previously pre-
sented a particularly disturbing combination, since 
the therapeutic approach is completely different for 
these two complications. In the former a reduction 
of immunosuppression is indicated, whereas an in-
crease in immunosuppression is required to control 
rejection. However, with the recent advent of 
DHPG (gancic1ovir) therapy this problem can be 
managed much more easily. 
It is well-established that retransplantation has 
significantly reduced the number of patients dying 
after liver transplantation (9). However, in this 
study retransplantation was associated with an in-
creased mortality. The mortality rate in patients 
who received a single liver transplant was 20%, 
compared to 50% in patients who underwent three 
transplants. These findings are not surprising or 
completely unexpected in this particular study, 
since the pediatric patients undergoing retransplan-
tation had multiple complications and were often 
moribund and a majority were emergent because 
of the etiology. This is in contrast to adults where 
the same complications may not be as devastating 
as in small children. Also the etiology of chronic 
rejection is more common in adults and gives much 
better results with retransplantation. Adult patients 
do not have to wait as long for a new liver as small 
children. 
The extremely high mortality of third transplant 
recipients has important implications. It raises the 
question whether pediatric liver grafts, which are 
in short supply, should be wasted in these patients 
or should be used preferentially in first transplant 
recipients. The policy in Pittsburgh is to consider 
each case on its own merits. 
The results after liver transplantation have im-
proved dramatically in recent years with l-yr sur-
vival rates exceeding 70% in children (3). However, 
this detailed analysis of the causes of death after 
pediatric liver transplantation in a large group of 
patients has revealed that advances in certain areas 
could lead to even better results. Improvements in 
the selection and management of the donor and in 
organ preservation should reduce the incidence of 
primary graft non-function. New preservation 
fluids are under investigation at the present time 
(22). New and more selective immunosuppressive 
agents with less toxicity would prevent or treat 
rejection episodes without compromising the reci-
pient, and thus diminish the complications associ-
ated with over-immunosuppression, including op-
portunistic infections and Iymphoproliferative dis-
orders (23). 
Further study of the pathogenesis and etiology 
of hepatic artery thrombosis is needed and should 
result in a reduction of the incidence of this major 
and devastating complication. The problem of viral 
infections, in particular cytomegalovirus infections, 
may become easier to manage in the future with 
the introduction of new antiviral agents i.e., gan-
ciclovir. Many children who require urgent retrans-
plantation often deteriorate while awaiting a suit-
able pediatric donor. The use of partially hepatec-
tomized adult livers would make it possible to 
retransplant these patients under more optimal cir-
cumstances and thus improve the results after re-
transplantation. 
In summary, this study has defined specific prob-
lema tic areas and complications of orthotopic liver 
transplantation which are responsible for mortality 
in pediatric patients. Careful evaluation and study 
of these individual negative factors will allow even 
further improvement in these already superior re-
sults. 
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